Skip to main content
. 2021 Feb 2;21(4):245. doi: 10.3892/ol.2021.12506

Figure 1.

Figure 1.

Upregulation of FASN protein in DEL patients. (A) Representative immunohistochemical staining of FASN and Ki67 proteins in tissues (magnification, ×400). Tissues were divided into three groups according to FASN expression intensity scores: 0, negative (left), 1–2, low-FASN expression (middle), 3, high-FASN expression (right). (B) The FASN expression scores in 87 patients with DLBCL, compared with 15 patients with RLH. (C) The FASN expression score in DEL, compared with non-DEL patients. Values shown are the mean ± standard error of the mean. Scale bar, 100 µm. FASN, fatty acid synthase; DLBCL, diffuse large B-cell lymphoma; RLH, reactive lymphoid hyperplasia; DEL, double-expressor lymphoma.